l carnitine tmao nature medicine 2013 koeth Gut Microbiota-Derived TMAO: A Causal Factor Promoting Atherosclerotic Cardiovascular Disease? Elucidation of an anaerobic pathway

10.1016/j.celrep.2016.05.009 Cell Rep 171

Die folgenden Empfehlungen scheinen ideal fr die entsprechende Form darzustellen (5): Acetyl-L-Carnitin: 600-2.500 mg pro Tag L-Carnitin L-Tartrat: 1.000-4.000 mg pro Tag Propionyl-L-Carnitin: 1.000-4.000 mg pro Tag *Propionyl-L-Carnitin ist hnlich zu den anderen Formen und besitzt die Fhigkeit bei Durchblutungsproblemen zu helfen, sowie die Energieproduktion zu verbessern (1)

Clinical Pearl: Ideal Candidates for Combination Therapy Patients that will greatly benefit from L-carnitine adjunctive therapy: Report persistent fatigue despite adequate weight loss on GLP-1 therapy alone Demonstrate signs of muscle loss or declining lean body mass during treatment Have plateaued in their weight loss despite medication optimization Present with metabolic syndrome features beyond elevated BMI (dyslipidemia, insulin resistance) Engage in regular physical activity and seek enhanced athletic performance alongside weight management Monitoring Parameters Regular assessment should include: Weight and body composition measurements every 4-6 weeks Lipid panel and HbA1c at 3-month intervals Liver function tests at baseline and 6 months (L-carnitine may affect hepatic fat metabolism) Patient-reported outcomes: energy levels, GI tolerability, exercise capacity Prescribing Patterns & Updates Growing Interest in Combination Metabolic Therapies Clinical practice patterns indicate increasing adoption of adjunctive therapies alongside GLP-1 medications

You can take two capsules of Getmy Mettle L-carnitine L- tartrate capsules everyday half an hour before or after your workout sessions or any meal, preferably breakfast

Sanagorski, R